INMD
InModeCNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-02
Current thesis
The constructive post-print read is that Q1 revenue slightly exceeded the company preannouncement range, management reiterated FY2026 revenue guidance, the U.S. contributed meaningfully to growth, and the company still holds a very large cash and investment position of $537.2 million while continuing aggressive buybacks.
Posture
Mixed
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.3.
What can break
Buybacks support the stock but can be modified, suspended, or discontinued and do not resolve core end-market demand risk.
Momentum
33
Value
70
Sentiment
47
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $14.50 · Bull $17.00 · Bear $11.50
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-09 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $16.80
Why
Momentum33 · Δ7d -6.2
Value70 · Δ7d +0.3
Sentiment47 · Δ7d +4.3
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Value · See fundamentals
Momentum
33
34% active weight
Current posture
7d trendSoftening
Δ7d
-6.2
Δ21d
-16.1
Value
70
32% active weight
Current posture
7d trendFlat
Δ7d
+0.3
Δ21d
-1.5
Sentiment
47
33% active weight
Current posture
7d trendImproving
Δ7d
+4.3
Δ21d
+9.4
Why this grade
Composite grade C. Momentum 33.1 / Value 69.6 / Sentiment 47.2
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$861.05M
Beta
2.19
Shares Out
63.21M
P/E (TTM)
7.1
P/S (TTM)
2.63
P/FCF (TTM)
10.18
Rev YoY
-28.5%
EPS YoY
-47.7%
Gross Margin
+78.8%
Op Margin
+23.9%
Net Debt
-$596.47M
Current Ratio
9.75
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology